Trial shows hydroxychloroquine fails in COVID-19 hospital patients
Large UK study of 1542 hospitalized patients finds hydroxychloroquine does not reduce deaths or hospital stays. After 28 days, mortality was 25.7% with hydroxychloroquine versus 23.5% with usual care, a difference likely due to chance. Oxford researchers say no meaningful mortality benefit. Results not yet fully published.
MENTIONED IN THIS ARTICLE
United Kingdom
University of Oxford
Lancet
Oxford
England
Scotland
Wales
Northern Ireland
ER visits for heart issues fall during pandemic study says
CDC data from 43 states show a 42 percent drop in heart attack and chest pain ER visits from late March to April, with fewer visits for nearly all injuries while respiratory illness and pneumonia rose. Wayne Rosamond of UNC notes fear of seeking care and delayed treatment amid COVID-19.
MENTIONED IN THIS ARTICLE
New York
U.S
Centers For Disease Control and Prevention
CDC
LMH Health Patient Advocate Helps Seek Answers
LMH Health offers a patient advocate led by Mardi Bowlin, patient safety officer, to bridge communication between patients, families, and care teams. The advocate prioritizes patient safety, addresses concerns, and assists with appointments and prescriptions while navigating authorization limits for information.
MENTIONED IN THIS ARTICLE
LMH Health
Mardi Bowlin
Marci Bowlin
Also Mentioned on This Page
Trump
Associated Press
Peter Horby
Donald Trump
Mike Stobbe
Wayne Rosamond
University of North Carolina
Bowlin
Lawrence
Megan
Lmh.org
Megan Hill
JYS & Girls